1. Home
  2. CFLT vs ROIV Comparison

CFLT vs ROIV Comparison

Compare CFLT & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Confluent Inc.

CFLT

Confluent Inc.

HOLD

Current Price

$30.14

Market Cap

7.7B

Sector

Technology

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$22.50

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFLT
ROIV
Founded
2014
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
14.1B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CFLT
ROIV
Price
$30.14
$22.50
Analyst Decision
Buy
Strong Buy
Analyst Count
32
8
Target Price
$29.93
$24.31
AVG Volume (30 Days)
19.4M
8.4M
Earning Date
02-10-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,113,149,000.00
$20,329,000.00
Revenue This Year
$22.76
N/A
Revenue Next Year
$16.57
$741.42
P/E Ratio
N/A
N/A
Revenue Growth
21.57
N/A
52 Week Low
$15.64
$8.73
52 Week High
$37.90
$23.47

Technical Indicators

Market Signals
Indicator
CFLT
ROIV
Relative Strength Index (RSI) 77.78 61.36
Support Level $29.95 $21.60
Resistance Level $30.07 $22.76
Average True Range (ATR) 0.16 0.84
MACD 0.07 0.04
Stochastic Oscillator 98.84 70.91

Price Performance

Historical Comparison
CFLT
ROIV

About CFLT Confluent Inc.

Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: